HIV/AIDS Therapy
Race is not associated with pharmacokinetics of nevirapine
Published in Blood Weekly, October 28th, 2004
According to recent research from the Netherlands, "The effect of race on the pharmacokinetics of nevirapine was investigated in a nonselected population.
"Included patients were ambulatory HIV-1-infected patients from the outpatient clinics of the Academic Medical Center and the Slotervaart Hospital, Amsterdam, The Netherlands. All patients were using nevirapine as part of their antiretroviral regimen and had at least one plasma concentration available for analysis."
"From the included patients, gender, age, race, hepatitis C status, baseline ASAT value, and body...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2004-10-28)
More Articles from Blood Weekly
- Cord Blood
Umbilical cord blood transplant after nonmyeloablative conditioning is promising - Hemophilia
Viruses bearing transgene generate coagulation factor in hemophilia A models - Liver Regeneration
Fluidized bed bioreactor has potential for extracorporeal liver supply - Non-Hodgkin Lymphoma
Allogeneic blood transfusion does not increase risk of non-Hodgkin lymphoma - Obstetrics
Diagnosis and management of twin-twin transfusion syndrome reviewed - Tissue Engineering
Novel scaffolds may be very useful for vascular tissue engineering - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
